Cargando…
Development of Chitosan-based Dry Powder Inhalation System of Cisplatin for Lung Cancer
Cisplatin, a platinum compound, exerts its cytotoxic effects by coordinating to DNA where it inhibits both replication and transcription, and induces programmed cell death. It is used in the treatment of non-small cell lung cancer. In the present study, an attempt was made to achieve better treatmen...
Autores principales: | Singh, D. J., Lohade, A. A., Parmar, J. J., Hegde, Darshana D., Soni, P., Samad, A., Menon, Mala D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687921/ https://www.ncbi.nlm.nih.gov/pubmed/23798777 http://dx.doi.org/10.4103/0250-474X.110584 |
Ejemplares similares
-
Inhalational System for Etoposide Liposomes: Formulation Development and In Vitro Deposition
por: Parmar, J. J., et al.
Publicado: (2011) -
Development and Evaluation of Inhalational Liposomal System of Budesonide for Better Management of Asthma
por: Parmar, J. J., et al.
Publicado: (2010) -
Development and evaluation of Chitosan nanoparticles based dry powder inhalation formulations of Prothionamide
por: Debnath, Sujit Kumar, et al.
Publicado: (2018) -
Dry Powder Inhalation for Lung Delivery in Cystic Fibrosis
por: Han, Xiaoxuan, et al.
Publicado: (2023) -
Ciprofloxacin dry powder inhaler in cystic fibrosis
por: Elborn, J Stuart
Publicado: (2016)